Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 9 Months Ended 175 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Income Statement [Abstract]          
Net sales             $ 69,000
Cost of goods sold             24,120
Gross profit             44,880
Operating expenses 2,429,153 2,129,273 6,288,872 4,640,508 50,433,507
Research and development expenses 177,311 379,391 528,201 931,959 7,973,198
Non-cash patent settlement cost             1,610,066
Loss before other income (expense) (2,606,464) (2,508,664) (6,817,073) (5,572,467) (59,971,891)
Other income (expense) 4,593 112,453 20,568 150,903 212,540
Interest income             16,342
Interest and financing expense (774,232) (1,014,043) (3,588,522) (4,810,735) (20,265,138)
Change in fair value of derivative liabilities (2,688,512) 1,158,500 (2,856,087) 2,722,084 (727,886)
Gain on extinguishment of derivative liabilities 1,377,911    1,463,487    1,463,487
Costs of private placement             (1,640,715)
Costs to induce conversion of notes             (469,043)
Loss on disposition of equipment             (14,426)
Settlement of Debt Due Morale/ Matthews             (927,903)
Settlement of litigation and debt 16,000    239,775    1,504,796
Loss before provision for income taxes (4,670,704) (2,251,754) (11,537,852) (7,510,215) (80,819,837)
Provision for income taxes       800 800 8,282
Net loss $ (4,670,704) $ (2,251,754) $ (11,538,652) $ (7,511,015) $ (80,828,119)
Net loss per share, basic and diluted $ (0.04) $ (0.02) $ (0.09) $ (0.07)  
Weighted average common shares outstanding,basic and diluted 129,389,182 109,394,365 124,978,300 100,944,733